Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sapphire Capital Partners is a private UK venture capital and fund management firm, not a biotech, pharma, or healthcare operating company. The firm specializes in launching, managing, and supporting sector-focused venture capital funds, with a particular emphasis on SEIS and EIS structures and broader alternative investment fund management. Sapphire appears to operate as an FCA-authorized investment manager and fund incubator serving fund sponsors and investors rather than developing therapeutics, diagnostics, or healthcare products itself. While it has participated in or managed funds with exposure to healthcare-related themes, the company itself is best categorized as a financial services and venture capital platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sapphire Capital Partners.